Cytosorbents Corporation (NASDAQ:CTSO) Shorted Shares Increased 18.3% After Market Selling

September 12, 2017 - By Michael Collier

 Cytosorbents Corporation (NASDAQ:CTSO) Shorted Shares Increased 18.3% After Market Selling

Investors sentiment decreased to 1.25 in 2016 Q4. Its down 0.53, from 1.78 in 2016Q3. It turned negative, as 4 investors sold Cytosorbents Corp shares while 8 reduced holdings. 7 funds opened positions while 8 raised stakes. 1.20 million shares or 2.14% less from 1.23 million shares in 2016Q3 were reported.
Segantii Cap Management holds 0.01% or 4,100 shares in its portfolio. Moreover, Vanguard has 0% invested in Cytosorbents Corp (NASDAQ:CTSO) for 545,804 shares. Northern Trust has 24,574 shares. Blackrock Invest Mngmt Ltd Liability Corporation has 3,776 shares for 0% of their portfolio. Royal Commercial Bank Of Canada has invested 0% in Cytosorbents Corp (NASDAQ:CTSO). California Employees Retirement holds 0% or 46,100 shares in its portfolio. Manatuck Hill Prns Lc reported 50,000 shares or 0.13% of all its holdings. Blackrock holds 0% of its portfolio in Cytosorbents Corp (NASDAQ:CTSO) for 400 shares. Kcg Inc accumulated 17,268 shares. The Kansas-based Creative Planning has invested 0% in Cytosorbents Corp (NASDAQ:CTSO). Morgan Stanley invested in 0% or 1,153 shares. State Street Corporation accumulated 0% or 12,000 shares. 45,157 were accumulated by Blackrock Institutional Trust Na. 2,164 were reported by Manufacturers Life Insurance Com The. Blackrock Fund holds 0% or 64,489 shares in its portfolio.

Since May 15, 2017, it had 7 insider buys, and 0 insider sales for $80,608 activity. The insider Mortensen Eric R. bought $10,100. Another trade for 2,500 shares valued at $10,000 was made by Capponi Vincent on Thursday, June 8. 1,500 Cytosorbents Corp (NASDAQ:CTSO) shares with value of $6,180 were bought by BATOR MICHAEL G.. On Monday, May 15 the insider BLOCH KATHLEEN P. bought $4,341. Jones Edward Raymond had bought 2,500 shares worth $9,987 on Thursday, June 8.

The stock of Cytosorbents Corporation (NASDAQ:CTSO) registered an increase of 18.3% in short interest. CTSO’s total short interest was 1.14M shares in September as published by FINRA. Its up 18.3% from 964,100 shares, reported previously. With 179,800 shares average volume, it will take short sellers 6 days to cover their CTSO’s short positions. The short interest to Cytosorbents Corporation’s float is 5.54%.

About 39,356 shares traded. Cytosorbents Corp (NASDAQ:CTSO) has declined 4.26% since September 12, 2016 and is downtrending. It has underperformed by 20.96% the S&P500.

CytoSorbents Corporation is a critical care focused immunotherapy company. The company has market cap of $161.77 million. The Firm is engaged in commercializing its product, CytoSorb, which is a blood purification technology with focus in preventing or treating multiple organ failure. It currently has negative earnings. The Company’s purification technologies are based on biocompatible, porous polymer beads that remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption.

Cytosorbents Corp (NASDAQ:CTSO) Ratings Coverage

Among 6 analysts covering CytoSorbents (NASDAQ:CTSO), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. CytoSorbents had 10 analyst reports since October 29, 2015 according to SRatingsIntel. The company was maintained on Tuesday, May 30 by Aegis Capital. The stock of Cytosorbents Corp (NASDAQ:CTSO) earned “Buy” rating by Aegis Capital on Wednesday, October 26. On Tuesday, August 8 the stock rating was maintained by Maxim Group with “Buy”. Maxim Group maintained Cytosorbents Corp (NASDAQ:CTSO) on Wednesday, July 5 with “Buy” rating. The stock of Cytosorbents Corp (NASDAQ:CTSO) has “Buy” rating given on Tuesday, May 24 by Maxim Group. The company was maintained on Monday, July 17 by Maxim Group. The firm has “Buy” rating by WBB Securities given on Thursday, October 29. B. Riley & Co initiated the stock with “Buy” rating in Friday, October 7 report.

More notable recent Cytosorbents Corp (NASDAQ:CTSO) news were published by: Prnewswire.com which released: “CytoSorbents Selected to Present at Special Operations SOMSA 2017 Conference …” on May 24, 2017, also Prnewswire.com with their article: “CytoSorbents Expands Distribution and Sales of CytoSorb® to treat Deadly …” published on July 17, 2017, Seekingalpha.com published: “Cytosorbents: A Razor & Razor Blade Story” on June 28, 2017. More interesting news about Cytosorbents Corp (NASDAQ:CTSO) were released by: Prnewswire.com and their article: “CytoSorbents to Report Q1 2017 Operating and Financial Results” published on May 02, 2017 as well as Seekingalpha.com‘s news article titled: “Why CytoSorbents And Spectral Medical Inc Are Not Good Stocks For A Long Position” with publication date: August 04, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.